Invistics Corp Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Invistics Corp's estimated annual revenue is currently $3.8M per year.(i)
  • Invistics Corp's estimated revenue per employee is $116,000

Employee Data

  • Invistics Corp has 33 Employees.(i)

Invistics Corp's People

NameTitleEmail/Phone
1
VP SolutionsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$31.7M199N/AN/AN/A
#2
$5.2M45N/AN/AN/A
#3
$77.2M230N/AN/AN/A
#4
$35.2M246N/AN/AN/A
#5
$0.7M9N/AN/AN/A
#6
$0M30%$23MN/A
#7
$0.7M9N/AN/AN/A
#8
$5.6M48N/AN/AN/A
#9
$16.5M114N/AN/AN/A
#10
$2.4M24N/AN/AN/A
#11
$458.8M105224%$365MN/A
#12
$1M12N/AN/AN/A
#13
$0.1M50%$1.7MN/A
#14
$7.8M6028%N/AN/A
#15
$0.9M10N/AN/AN/A
#16
$22.3M137N/AN/AN/A
#17
$18.7M129N/AN/AN/A
#18
$4M380%$2MN/A
#19
$97.3M53719%N/AN/A
#20
$0.5M7N/AN/AN/A
Add Company

What Is Invistics Corp?

keywords:N/A

N/A

Total Funding

33

Number of Employees

$3.8M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Invistics Corp News

2021-10-13 - Invistics Enhances Drug Diversion Detection Software for Hospitals and Health Systems

Machine learning software, like Invistics’ cloud-based solution, give facilities an advantage in detecting and stopping this costly problem. All drug diversion programs should incorporate prevention and education, early identification, appropriate intervention, and re-integration, when possible. ...

2021-06-16 - Research Study Finds Three in Five Respondents Are Not Confident in the Effectiveness of Their Organization’s Drug Diversion Program

ATLANTA (PRWEB) June 16, 2021 Invistics, the leading provider of cloud-based software solutions that improve inventory visibility and analytics across complex healthcare systems and global supply chains, has released a new study on the state of drug diversion in America. The term “drug diversio ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.6M330%N/A
#2
$7.8M330%N/A
#3
$8.8M3410%N/A
#4
$7.9M340%N/A
#5
$7.9M3417%N/A